{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:14:45Z","timestamp":1789398885334,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T00:00:00Z","timestamp":1676764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T00:00:00Z","timestamp":1676764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mesenchymal stem cells (MSCs) therapy for sepsis has been extensively studied in the past decade; however, the treatment regimen and mechanism of action of MSCs remain elusive. Here, we attempted to understand the efficacy and mechanism of action of MSCs on rescuing mice with sepsis.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A mouse model of sepsis was produced by cecal ligation and puncture (CLP). Allogeneic adipose-derived MSCs (ADSCs) were administered by intravenous infusion at 6\u00a0h after CLP, and dose-related effects of ADSCs on these mice were determined by survival rate, histopathological changes, biochemical and coagulation parameters, bacterial load, and plasma levels of endotoxin and inflammatory cytokines. The tissue distribution of intravenously infused ADSCs in septic mice was investigated by pre-labeling ADSCs with the lipophilic membrane dye PKH26. RNA sequencing analysis was performed to assess the transcriptional changes in peripheral blood mononuclear cells (PBMCs) and the liver.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A significant therapeutic effect of ADSCs at a dose of 2\u2009\u00d7\u200910<jats:sup>7<\/jats:sup> cells\/kg in septic mice was evidenced by a remarkable reduction in mortality (35.89% vs. 8.89% survival rate), blood bacterial burden, systemic inflammation, and multiple organ damage. In contrast, ADSCs at a lower dose (1\u2009\u00d7\u200910<jats:sup>7<\/jats:sup> cells\/kg) failed to achieve any beneficial outcomes, while ADSCs at a higher dose (4\u2009\u00d7\u200910<jats:sup>7<\/jats:sup> cells\/kg) caused more early death within 24\u00a0h after CLP, retaining a steady survival rate of 21.42% thereafter. PKH26-labeled ADSCs were predominantly localized in the lungs of septic mice after intravenous infusion, with only a smaller proportion of PKH26-positive signals appearing in the liver and spleen. RNA sequencing analysis identified that insufficient phagocytic activity of PBMCs in addition to a hyperactivation of the hepatic immune response was responsible for the ineffectiveness of low-dose ADSCs therapy, and acute death caused by high-dose ADSCs infusion was associated with impaired coagulation signaling in PBMCs and exacerbated hepatic hypoxic injury.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings demonstrate a dose-specific effect of ADSCs on the treatment of sepsis due to dose-related interactions between exogenous stem cells and the host\u2019s microenvironment. Therefore, a precise dosing regimen is a prerequisite for ADSCs therapy for sepsis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-023-03253-3","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T21:03:09Z","timestamp":1676840589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dose-specific efficacy of adipose-derived mesenchymal stem cells in septic mice"],"prefix":"10.1186","volume":"14","author":[{"given":"Kui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulai","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. James","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,19]]},"reference":[{"issue":"8","key":"3253_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"7","key":"3253_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3253_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3949\/ccjm.87a.18143","volume":"87","author":"S Dugar","year":"2020","unstructured":"Dugar S, Choudhary C, Duggal A. Sepsis and septic shock: guideline-based management. Cleve Clin J Med. 2020;87(1):53\u201364.","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"3253_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4252\/wjsc.v7.i2.368","volume":"7","author":"E Lombardo","year":"2015","unstructured":"Lombardo E, van der Poll T, DelaRosa O, Dalemans W. Mesenchymal stem cells as a therapeutic tool to treat sepsis. World J Stem Cells. 2015;7(2):368\u201379.","journal-title":"World J Stem Cells"},{"key":"3253_CR5","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.17850","author":"MM Lalu","year":"2016","unstructured":"Lalu MM, Sullivan KJ, Mei SH, Moher D, Straus A, Fergusson DA, et al. Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial. Elife. 2016. https:\/\/doi.org\/10.7554\/eLife.17850.","journal-title":"Elife"},{"issue":"1","key":"3253_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13287-020-01730-7","volume":"11","author":"XY Sun","year":"2020","unstructured":"Sun XY, Ding XF, Liang HY, Zhang XJ, Liu SH, Bing H, et al. Efficacy of mesenchymal stem cell therapy for sepsis: a meta-analysis of preclinical studies. Stem Cell Res Ther. 2020;11(1):214.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3253_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/sctm.19-0202","volume":"9","author":"M Kabat","year":"2020","unstructured":"Kabat M, Bobkov I, Kumar S, Grumet M. Trends in mesenchymal stem cell clinical trials 2004\u20132018: is efficacy optimal in a narrow dose range? Stem Cells Transl Med. 2020;9(1):17\u201327.","journal-title":"Stem Cells Transl Med"},{"key":"3253_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.trsl.2018.04.006","volume":"199","author":"X He","year":"2018","unstructured":"He X, Ai S, Guo W, Yang Y, Wang Z, Jiang D, et al. Umbilical cord-derived mesenchymal stem (stromal) cells for treatment of severe sepsis: aphase 1 clinical trial. Transl Res. 2018;199:52\u201361.","journal-title":"Transl Res"},{"key":"3253_CR9","doi-asserted-by":"publisher","DOI":"10.23937\/2469-5696\/1410033","author":"G Gennadiy","year":"2018","unstructured":"Gennadiy G, Polina M, Elena P, Larisa K, Vera T, Eduard G, Valeriy S. The results of the single center pilot randomized russian clinical trial of mesenchymal stromal cells in severe neutropenic patients with septic shock (RUMCESS). Int J Blood Res Disord. 2018. https:\/\/doi.org\/10.23937\/2469-5696\/1410033.","journal-title":"Int J Blood Res Disord"},{"issue":"3","key":"3253_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1164\/rccm.201705-1006OC","volume":"197","author":"LA McIntyre","year":"2018","unstructured":"McIntyre LA, Stewart DJ, Mei SHJ, Courtman D, Watpool I, Granton J, et al. Cellular immunotherapy for septic shock A. Phase I clinical trial. Am J Respir Crit Care Med. 2018;197(3):337\u201347.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3253_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12890-020-01324-2","volume":"20","author":"PF Laterre","year":"2020","unstructured":"Laterre PF, Sanchez-Garcia M, van der Poll T, de la Rosa O, Cadogan KA, Lombardo E, et al. A phase Ib\/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit. BMC Pulm Med. 2020;20(1):309.","journal-title":"BMC Pulm Med"},{"key":"3253_CR12","doi-asserted-by":"crossref","unstructured":"Alverdy JC, Keskey R, Thewissen R. Can the cecal ligation and puncture model be repurposed to better inform therapy in human sepsis? Infect Immun. 2020; 88(9).","DOI":"10.1128\/IAI.00942-19"},{"issue":"1","key":"3253_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nprot.2008.214","volume":"4","author":"D Rittirsch","year":"2009","unstructured":"Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 2009;4(1):31\u20136.","journal-title":"Nat Protoc"},{"issue":"1","key":"3253_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/SHK.0000000000000565","volume":"46","author":"BP Yoseph","year":"2016","unstructured":"Yoseph BP, Klingensmith NJ, Liang Z, Breed ER, Burd EM, Mittal R, et al. Mechanisms of intestinal barrier dysfunction in sepsis. Shock. 2016;46(1):52\u20139.","journal-title":"Shock"},{"issue":"1","key":"3253_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4049\/jimmunol.1701677","volume":"201","author":"EL Heipertz","year":"2018","unstructured":"Heipertz EL, Harper J, Lopez CA, Fikrig E, Hughes ME, Walker WE. Circadian rhythms influence the severity of sepsis in mice via a TLR2-dependent, leukocyte-intrinsic mechanism. J Immunol. 2018;201(1):193\u2013201.","journal-title":"J Immunol"},{"key":"3253_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/1756-0500-7-233","volume":"7","author":"B Shrum","year":"2014","unstructured":"Shrum B, Anantha RV, Xu SX, Donnelly M, Haeryfar SM, McCormick JK, et al. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res Notes. 2014;7:233.","journal-title":"BMC Res Notes"},{"issue":"4","key":"3253_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tice.2010.04.003","volume":"42","author":"MF Taha","year":"2010","unstructured":"Taha MF, Hedayati V. Isolation, identification and multipotential differentiation of mouse adipose tissue-derived stem cells. Tissue Cell. 2010;42(4):211\u20136.","journal-title":"Tissue Cell"},{"issue":"4","key":"3253_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.cell.2014.07.017","volume":"158","author":"B Yang","year":"2014","unstructured":"Yang B, Treweek JB, Kulkarni RP, Deverman BE, Chen CK, Lubeck E, et al. Single-cell phenotyping within transparent intact tissue through whole-body clearing. Cell. 2014;158(4):945\u201358.","journal-title":"Cell"},{"issue":"1","key":"3253_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13287-019-1365-z","volume":"10","author":"JD Silva","year":"2019","unstructured":"Silva JD, Lopes-Pacheco M, de Castro LL, Kitoko JZ, Trivelin SA, Amorim NR, et al. Eicosapentaenoic acid potentiates the therapeutic effects of adipose tissue-derived mesenchymal stromal cells on lung and distal organ injury in experimental sepsis. Stem Cell Res Ther. 2019;10(1):264.","journal-title":"Stem Cell Res Ther"},{"issue":"W1","key":"3253_CR20","doi-asserted-by":"publisher","first-page":"W501","DOI":"10.1093\/nar\/gkx372","volume":"45","author":"W Luo","year":"2017","unstructured":"Luo W, Pant G, Bhavnasi YK, Blanchard SG Jr, Brouwer C. Pathview Web: user friendly pathway visualization and data integration. Nucleic Acids Res. 2017;45(W1):W501\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"3253_CR21","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J. NetworkAnalyst 30: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47(W1):W234.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"3253_CR22","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1093\/nar\/gkp1205","volume":"38","author":"A Ortiz-Barahona","year":"2010","unstructured":"Ortiz-Barahona A, Villar D, Pescador N, Amigo J, del Peso L. Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction. Nucleic Acids Res. 2010;38(7):2332\u201345.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3253_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"key":"3253_CR24","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1038\/emm.2014.28","volume":"46","author":"SM Han","year":"2014","unstructured":"Han SM, Han SH, Coh YR, Jang G, Chan Ra J, Kang SK, et al. Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells. Exp Mol Med. 2014;46:e101.","journal-title":"Exp Mol Med"},{"issue":"5","key":"3253_CR25","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1097\/CCM.0b013e31820eda29","volume":"39","author":"JL Vincent","year":"2011","unstructured":"Vincent JL, Nelson DR, Williams MD. Is worsening multiple organ failure the cause of death in patients with severe sepsis? Crit Care Med. 2011;39(5):1050\u20135.","journal-title":"Crit Care Med"},{"key":"3253_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-3-319-16104-4_15","volume-title":"The impact of food bioactives on health","author":"CR Kleiveland","year":"2015","unstructured":"Kleiveland CR. Peripheral blood mononuclear cells. In: Verhoeckx K, Cotter P, L\u00f3pez-Exp\u00f3sito I, Kleiveland C, Lea T, Mackie A, Requena T, Swiatecka D, Wichers H, editors. The impact of food bioactives on health. Cham: Springer International Publishing; 2015. p. 161\u20137. https:\/\/doi.org\/10.1007\/978-3-319-16104-4_15."},{"issue":"10","key":"3253_CR27","doi-asserted-by":"publisher","first-page":"L1003","DOI":"10.1152\/ajplung.00180.2011","volume":"302","author":"A Krasnodembskaya","year":"2012","unstructured":"Krasnodembskaya A, Samarani G, Song Y, Zhuo H, Su X, Lee JW, et al. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol. 2012;302(10):L1003\u201313.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"Pt B","key":"3253_CR28","doi-asserted-by":"publisher","first-page":"107087","DOI":"10.1016\/j.intimp.2020.107087","volume":"89","author":"V Kumar","year":"2020","unstructured":"Kumar V. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Int Immunopharmacol. 2020;89(Pt B):107087.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3253_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K N\u00e9meth","year":"2009","unstructured":"N\u00e9meth K, Leelahavanichkul A, Yuen PST, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Xuzhen H, Jelinek I, Star RA, Mezey \u00c9. Bone marrow stromal cells attenuate sepsis via prostaglandin E2\u2013dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15(1):42\u20139. https:\/\/doi.org\/10.1038\/nm.1905.","journal-title":"Nat Med"},{"issue":"8","key":"3253_CR30","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","volume":"182","author":"SH Mei","year":"2010","unstructured":"Mei SH, Haitsma JJ, Dos Santos CC, Deng Y, Lai PF, Slutsky AS, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med. 2010;182(8):1047\u201357.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3253_CR31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/gut.2008.168534","volume":"58","author":"E Gonzalez-Rey","year":"2009","unstructured":"Gonzalez-Rey E, Anderson P, Gonz\u00e1lez MA, Rico L, B\u00fcscher D, Delgado M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut. 2009;58(7):929.","journal-title":"Gut"},{"key":"3253_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tice.2019.07.009","volume":"60","author":"Z Zarei-Behjani","year":"2019","unstructured":"Zarei-Behjani Z, Soleimani M, Atashi A, Ebrahimi-Barough S, Ai J, Hamidieh AA. Tracking of GFP-labeled unrestricted somatic stem cells transplanted in the sepsis mouse model. Tissue Cell. 2019;60:33\u20137.","journal-title":"Tissue Cell"},{"issue":"2","key":"3253_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/SHK.0000000000000080","volume":"41","author":"CJ Luo","year":"2014","unstructured":"Luo CJ, Zhang FJ, Zhang L, Geng YQ, Li QG, Hong Q, et al. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Shock. 2014;41(2):123\u20139.","journal-title":"Shock"},{"issue":"1","key":"3253_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000047856","volume":"169","author":"J Gao","year":"2001","unstructured":"Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169(1):12\u201320.","journal-title":"Cells Tissues Organs"},{"key":"3253_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;3:297.","journal-title":"Front Immunol"},{"issue":"1","key":"3253_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1476-9255-9-33","volume":"9","author":"J Li","year":"2012","unstructured":"Li J, Li D, Liu X, Tang S, Wei F. Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats. J Inflamm. 2012;9(1):33\u201333.","journal-title":"J Inflamm"},{"issue":"2","key":"3253_CR37","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S1499-3872(15)60354-X","volume":"14","author":"JF Yang","year":"2015","unstructured":"Yang JF, Cao HC, Pan QL, Yu J, Li J, Li LJ. Mesenchymal stem cells from the human umbilical cord ameliorate fulminant hepatic failure and increase survival in mice. Hepatobiliary Pancreat Dis Int. 2015;14(2):186\u201393.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"3253_CR38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13287-019-1295-9","volume":"10","author":"C Laroye","year":"2019","unstructured":"Laroye C, Boufenzer A, Jolly L, Cunat L, Alauzet C, Merlin JL, et al. Bone marrow vs Wharton\u2019s jelly mesenchymal stem cells in experimental sepsis: a comparative study. Stem Cell Res Ther. 2019;10(1):192.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"3253_CR39","first-page":"1778","volume":"36","author":"D Perlee","year":"2018","unstructured":"Perlee D, van Vught LA, Scicluna BP, Maag A, Lutter R, Kemper EM, et al. Intravenous infusion of human adipose mesenchymal stem cells modifies the host response to lipopolysaccharide in humans: a randomized, single-blind, parallel group. Placebo Controlled Trial Stem Cells. 2018;36(11):1778\u201388.","journal-title":"Placebo Controlled Trial Stem Cells"},{"key":"3253_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ebiom.2016.09.011","volume":"12","author":"DK Packham","year":"2016","unstructured":"Packham DK, Fraser IR, Kerr PG, Segal KR. Allogeneic mesenchymal precursor cells (MPC) in diabetic nephropathy: a randomized, placebo-controlled, Dose escalation study. EBioMedicine. 2016;12:263\u20139.","journal-title":"EBioMedicine"},{"issue":"1","key":"3253_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00134-021-06570-4","volume":"48","author":"G Bellingan","year":"2022","unstructured":"Bellingan G, Jacono F, Bannard-Smith J, Brealey D, Meyer N, Thickett D, et al. Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1\/2 trial. Intensive Care Med. 2022;48(1):36\u201344.","journal-title":"Intensive Care Med"},{"issue":"5","key":"3253_CR42","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","volume":"16","author":"DC Hess","year":"2017","unstructured":"Hess DC, Wechsler LR, Clark WM, Savitz SI, Ford GA, Chiu D, et al. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017;16(5):360\u20138.","journal-title":"Lancet Neurol"},{"issue":"2","key":"3253_CR43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/CCM.0b013e31819584f9","volume":"37","author":"JJ Hoogerwerf","year":"2009","unstructured":"Hoogerwerf JJ, de Vos AF, Levi M, Bresser P, van der Zee JS, Draing C, et al. Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide. Crit Care Med. 2009;37(2):619\u201325.","journal-title":"Crit Care Med"},{"issue":"7","key":"3253_CR44","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/01.ATV.14.7.1202","volume":"14","author":"S Steinemann","year":"1994","unstructured":"Steinemann S, Ulevitch RJ, Mackman N. Role of the lipopolysaccharide (LPS)-binding protein\/CD14 pathway in LPS induction of tissue factor expression in monocytic cells. Arterioscler Thromb. 1994;14(7):1202\u20139.","journal-title":"Arterioscler Thromb"},{"issue":"2","key":"3253_CR45","doi-asserted-by":"publisher","first-page":"G171","DOI":"10.1152\/ajpgi.00402.2017","volume":"315","author":"A Pant","year":"2018","unstructured":"Pant A, Kopec AK, Luyendyk JP. Role of the blood coagulation cascade in hepatic fibrosis. Am J Physiol-Gastroint Liver Physiol. 2018;315(2):G171\u20136. https:\/\/doi.org\/10.1152\/ajpgi.00402.2017.","journal-title":"Am J Physiol-Gastroint Liver Physiol"},{"issue":"10","key":"3253_CR46","doi-asserted-by":"publisher","first-page":"e110338","DOI":"10.1371\/journal.pone.0110338","volume":"9","author":"YH Chao","year":"2014","unstructured":"Chao YH, Wu HP, Wu KH, Tsai YG, Peng CT, Lin KC, et al. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis. PLoS ONE. 2014;9(10):e110338.","journal-title":"PLoS ONE"},{"issue":"8","key":"3253_CR47","doi-asserted-by":"publisher","first-page":"e104392","DOI":"10.1371\/journal.pone.0104392","volume":"9","author":"R Zhou","year":"2014","unstructured":"Zhou R, Li Z, He C, Li R, Xia H, Li C, et al. Human umbilical cord mesenchymal stem cells and derived hepatocyte-like cells exhibit similar therapeutic effects on an acute liver failure mouse model. PLoS ONE. 2014;9(8):e104392.","journal-title":"PLoS ONE"},{"issue":"1 Suppl 1","key":"3253_CR48","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1097\/TA.0000000000001485","volume":"83","author":"BA Christy","year":"2017","unstructured":"Christy BA, Herzig MC, Montgomery RK, Delavan C, Bynum JA, Reddoch KM, et al. Procoagulant activity of human mesenchymal stem cells. J Trauma Acute Care Surg. 2017;83(1 Suppl 1):S164\u20139.","journal-title":"J Trauma Acute Care Surg"},{"issue":"19","key":"3253_CR49","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1089\/scd.2015.0120","volume":"24","author":"G Moll","year":"2015","unstructured":"Moll G, Ignatowicz L, Catar R, Luecht C, Sadeghi B, Hamad O, et al. Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua. Stem Cells Devel. 2015;24(19):2269\u201379.","journal-title":"Stem Cells Devel"},{"issue":"2","key":"3253_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbrc.2012.12.134","volume":"431","author":"K Tatsumi","year":"2013","unstructured":"Tatsumi K, Ohashi K, Matsubara Y, Kohori A, Ohno T, Kakidachi H, et al. Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism. Biochem Biophys Res Commun. 2013;431(2):203\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3253_CR51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/01902148.2021.1897191","volume":"47","author":"G Liu","year":"2021","unstructured":"Liu G, Di Z, Hao C, Wang W, Pei T, Zheng L, et al. Effects of different concentrations of mesenchymal stem cells treatment on LPS-induced acute respiratory distress syndrome rat model. Exp Lung Res. 2021;47(5):226\u201338.","journal-title":"Exp Lung Res"},{"key":"3253_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13287-015-0192-0","volume":"6","author":"F Alcayaga-Miranda","year":"2015","unstructured":"Alcayaga-Miranda F, Cuenca J, Martin A, Contreras L, Figueroa FE, Khoury M. Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis. Stem Cell Res Ther. 2015;6:199.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3253_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto Encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03253-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03253-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03253-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T22:02:25Z","timestamp":1676844145000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03253-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,19]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3253"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03253-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,19]]},"assertion":[{"value":"16 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Animal Ethics Committee of West China Hospital Sichuan University (No.20211135A; Title: Study of adipose-derived mesenchymal stem cells in septic mice; Date of approval: March 23, 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}